个性化文献订阅>期刊> ACS Medicinal Chemistry Letters
 

Binding Model for the Interaction of Anticancer Arylsulfonamides with the p300 Transcription Cofactor

  作者 SHI QI; YIN SHAOMAN; KALUZ STEFAN; NI NANTING; DEVI NARRA SAROJINI; MUN JIYOUNG; WANG DANZHU; DAMERA KRISHNA; CHEN WEIXUAN; BURROUGHS SARAH; MOORING SUAZETTE REID; GOODMAN MARK M; VAN MEIR ERWIN G; WANG BINGHE; SNYDER JAMES P  
  选自 期刊  ACS Medicinal Chemistry Letters;  卷期  2012年3-8;  页码  620-625  
  关联知识点  
 

[摘要]Hypoxia inducible factors (HIFs) are transcription factors that activate expression of multiple gene products and promote tumor adaptation to a hypoxic environment. To become transcriptionally active, HIFs associate with cofactors p300 or CBP. Previously, we found that arylsulfonamides can antagonize HIP transcription in a bioassay, block the p300/HIF-1 alpha interaction, and exert potent anticancer activity in several animal models. In the present work, KCN1-bead affinity pull down, C-14-labeled KCN1 binding, and KCN1-surface plasmon resonance measurements provide initial support for a mechanism in which KCN1 can bind to the CH1 domain of p300 and likely prevent the p300/HIF-1 alpha assembly. Using a previously reported NMR structure of the p300/HIP-1 alpha complex, we have identified potential binding sites in the p300-CH1 domain. A two-site binding model coupled with IC50 values has allowed establishment of a modest ROC-based enrichment and creation of a guide for future analogue synthesis.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内